These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14563575)

  • 1. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.
    Schächinger V; Hamm CW; Münzel T; Haude M; Baldus S; Grube E; Bonzel T; Konorza T; Köster R; Arnold R; Haase J; Probst P; vom Dahl J; Neumann FJ; Mudra H; Hennen B; Thiele L; Zeiher AM;
    J Am Coll Cardiol; 2003 Oct; 42(8):1360-9. PubMed ID: 14563575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
    JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.
    Stankovic G; Colombo A; Presbitero P; van den Branden F; Inglese L; Cernigliaro C; Niccoli L; Bartorelli AL; Rubartelli P; Reifart N; Heyndrickx GR; Saunamäki K; Morice MC; Sgura FA; Di Mario C;
    Circulation; 2003 Jul; 108(1):37-42. PubMed ID: 12821546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-covered stents for the treatment of aortocoronary vein graft disease.
    Baldus S; Köster R; Reimers J; Hamm CW
    Catheter Cardiovasc Interv; 2000 May; 50(1):83-8. PubMed ID: 10816288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covered stent grafts: role in intervention of coronary arteries and degenerated vein grafts.
    Schächinger V; Zeiher AM
    Z Kardiol; 2002; 91 Suppl 3():58-63. PubMed ID: 12641016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: the Symbiot II trial.
    Laarman GJ; Kiemeneij F; Mueller R; Guagliumi G; Cobaugh M; Serruys PW;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):361-8. PubMed ID: 15736242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous treatment of saphenous vein graft disease: the ongoing challenge.
    Baim DS
    J Am Coll Cardiol; 2003 Oct; 42(8):1370-2. PubMed ID: 14563576
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of aortocoronary graft lesions with graft-stents.
    Boztosun B; Gunes Y; Olcay A; Esen AM; Esen OB; Saglam M; Kirma C
    Coron Artery Dis; 2006 May; 17(3):271-4. PubMed ID: 16728878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.
    Blackman DJ; Choudhury RP; Banning AP; Channon KM
    J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of aortocoronary vein graft lesions with membrane-covered stents: A multicenter surveillance trial.
    Baldus S; Köster R; Elsner M; Walter DH; Arnold R; Auch-Schwelk W; Berger J; Rau M; Meinertz T; Zeiher AM; Hamm CW
    Circulation; 2000 Oct; 102(17):2024-7. PubMed ID: 11044414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polytetrafluoroethylene-covered stent for the treatment of narrowings in aorticocoronary saphenous vein grafts.
    Briguori C; De Gregorio J; Nishida T; Adamian M; Albiero R; Tucci G; Di Mario C; Colombo A
    Am J Cardiol; 2000 Aug; 86(3):343-6. PubMed ID: 10922449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial.
    Turco MA; Buchbinder M; Popma JJ; Weissman NJ; Mann T; Doucet S; Johnson WL; Greenberg JD; Leadley K; Russell ME
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):379-88. PubMed ID: 16892434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
    J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.
    Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Arioli F; Mussardo M; Piraino D; Figini F; Carlino M; Montorfano M; Chieffo A; Colombo A
    Am J Cardiol; 2010 Dec; 106(12):1721-7. PubMed ID: 21126616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Safety and Efficacy of New-Generation Single-Layer Polytetrafluorethylene Covered Coronary Stents.
    Voll F; Koch T; Tölg R; Lenz T; Schroeter M; Lenders G; Hokken R; Cassese S; Xhepa E; Schunkert H; Kastrati A; Kufner S
    Cardiovasc Revasc Med; 2023 Jul; 52():30-36. PubMed ID: 36822974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts.
    Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW
    Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results.
    Gercken U; Lansky AJ; Buellesfeld L; Desai K; Badereldin M; Mueller R; Selbach G; Leon MB; Grube E
    Catheter Cardiovasc Interv; 2002 Jul; 56(3):353-60. PubMed ID: 12112888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.
    Savage MP; Douglas JS; Fischman DL; Pepine CJ; King SB; Werner JA; Bailey SR; Overlie PA; Fenton SH; Brinker JA; Leon MB; Goldberg S
    N Engl J Med; 1997 Sep; 337(11):740-7. PubMed ID: 9287229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.